1. Home
  2. JNVR vs MIRA Comparison

JNVR vs MIRA Comparison

Compare JNVR & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JNVR
  • MIRA
  • Stock Information
  • Founded
  • JNVR 2018
  • MIRA 2020
  • Country
  • JNVR United States
  • MIRA United States
  • Employees
  • JNVR N/A
  • MIRA N/A
  • Industry
  • JNVR Finance: Consumer Services
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • JNVR Finance
  • MIRA Health Care
  • Exchange
  • JNVR Nasdaq
  • MIRA Nasdaq
  • Market Cap
  • JNVR 8.9M
  • MIRA 9.4M
  • IPO Year
  • JNVR 2023
  • MIRA 2023
  • Fundamental
  • Price
  • JNVR $0.83
  • MIRA $0.59
  • Analyst Decision
  • JNVR
  • MIRA
  • Analyst Count
  • JNVR 0
  • MIRA 0
  • Target Price
  • JNVR N/A
  • MIRA N/A
  • AVG Volume (30 Days)
  • JNVR 1.0M
  • MIRA 38.0K
  • Earning Date
  • JNVR 07-16-2024
  • MIRA 05-13-2024
  • Dividend Yield
  • JNVR N/A
  • MIRA N/A
  • EPS Growth
  • JNVR N/A
  • MIRA N/A
  • EPS
  • JNVR N/A
  • MIRA N/A
  • Revenue
  • JNVR $1,947,052.00
  • MIRA N/A
  • Revenue This Year
  • JNVR N/A
  • MIRA N/A
  • Revenue Next Year
  • JNVR N/A
  • MIRA N/A
  • P/E Ratio
  • JNVR N/A
  • MIRA N/A
  • Revenue Growth
  • JNVR N/A
  • MIRA N/A
  • 52 Week Low
  • JNVR $0.70
  • MIRA $0.51
  • 52 Week High
  • JNVR $5.50
  • MIRA $6.95
  • Technical
  • Relative Strength Index (RSI)
  • JNVR 46.04
  • MIRA 37.81
  • Support Level
  • JNVR $0.71
  • MIRA $0.51
  • Resistance Level
  • JNVR $1.01
  • MIRA $0.62
  • Average True Range (ATR)
  • JNVR 0.10
  • MIRA 0.05
  • MACD
  • JNVR 0.01
  • MIRA -0.00
  • Stochastic Oscillator
  • JNVR 28.10
  • MIRA 34.43

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: